Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-23-006213

10% owner bought 1,923,076 shares at $13.00 ($24,999,988)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-20 Purchase : show line 1 in the form +1,923,076 $13.00 $24,999,988 11,609,704 I
Open-market purchases · 1,923,076 sh · avg $13.00 · $24,999,988
Loading xslF345X03/tm234291-1_4seq1.xml…